Watch Demo

Poland Antidiabetics Industry Outlook 2024 - 2028

See how Poland Antidiabetics performed compared to key markets such as Germany, France and Italy.

Key Market Indicators

Poland's insulin export market is projected to decline slightly over the next five years, with values expected to drop from approximately $15.4 million in 2023 to around $14.9 million by 2028. This represents an average annual decrease of 0.7%. Despite this recent downturn, Poland has seen a historical growth in its insulin supply, which has increased by an average of 2.5% annually since 1999. In the global rankings for 2023, Poland occupied the 16th spot, while Ukraine surged ahead with $15.4 million in exports. France, Italy, and China secured the second, third, and fourth positions, respectively. On the import front, Poland's insulin market is also expected to see a slight decline. By 2028, imports are forecasted to reach roughly $128.3 million, down from $131.9 million in 2023. This indicates an average yearly decrease of 0.6%. Since 1999, the country's demand for imported insulin has decreased by an average of 1.6% per year.

Marketing Banner

Poland Antidiabetics Market Data and Forecasts

How much will Poland Antidiabetics Market grow to 2028?

Forecast: Insulin in Dosage Market Size Value in Poland
Forecast: Import of Insulin in Dosage Forms to Poland
Forecast: Export of Insulin in Dosage Forms from Poland
Forecast: Import of Insulin to Poland
Forecast: Import of Insulin in Dosage Forms to Poland
More in Antidiabetics Industry for 2028